Commentary

Digital Ulcer Disease in Systemic Sclerosis

Publish date: May 18, 2012

 

Dr. Denton reported that he has financial relationships with
Actelion Pharmaceuticals, Aspreva, Biovitrum, Digna,
Encysive Pharmaceuticals, Genzyme, and Pfizer.

Pages

Recommended Reading

HIV Infection Complicates Rheumatologic Treatments and Vice Versa
MDedge Rheumatology
Panel Recommends Tofacitinib Approval for Refractory RA
MDedge Rheumatology
Biologics for RA Do Not Increase Solid Cancer Risk
MDedge Rheumatology
Joint Involvement Less Common in Presence of Sjögren's Autoantibodies
MDedge Rheumatology
Avoid Certain Vaccine-Biologic Combos
MDedge Rheumatology
Smokers Less Likely to Respond to Biologic Treatment for RA
MDedge Rheumatology
Could a Urine Test Predict Response to Biologics?
MDedge Rheumatology
ACR Releases Updated Lupus Nephritis Guidelines
MDedge Rheumatology
ACR Gives Special Consideration to Pregnancy in Nephritis Guidelines
MDedge Rheumatology
Scleroderma Malignancy Risk Linked to Antinuclear Antibodies
MDedge Rheumatology